Multiparametric Cell Cycle Analysis Using the Operetta High-Content Imager and Harmony Software with PhenoLOGIC
1Vernalis Research, Granta Park, Cambridge, CB21 6GB, United Kingdom.
Plos One
|July 29, 2015
Summary
A new high-content imaging assay accurately determines cell cycle distribution for drug discovery. This method aids in understanding small molecule mechanisms of action and potential toxicology liabilities.
Area of Science:
- Cell Biology
- Pharmacology
- Drug Discovery
Background:
- High-content imaging (HCI) enables single-cell phenotype characterization.
- Understanding cell cycle distribution is crucial for oncology drug discovery and toxicology assessment.
- Existing methods for cell cycle analysis can be time-consuming and less high-throughput.
Purpose of the Study:
- To describe a novel, high-throughput phenotypic assay for determining cell cycle distribution using HCI.
- To validate the assay's ability to analyze cell cycle phases and enable multiplexing with other markers.
- To provide a cost-effective and rapid method for small molecule mechanism of action and toxicity studies.
Main Methods:
- Utilized PerkinElmer Operetta HCI and Harmony software with PhenoLOGIC machine learning for cell segmentation.
- Employed DNA content, EdU incorporation, and pHH3 (S10) expression to define cell cycle phases.
- Demonstrated multiplexing capability with pharmacodynamic markers like γH2AX, Ki67, and BrdU.
Main Results:
- Successfully segmented single cells from clumps using PhenoLOGIC.
- Accurately classified cells into G1, S, G2, and M phases based on multiple biomarkers.
- Showcased multiplexing to assess cell cycle effects in specific subpopulations (e.g., DNA-damaged cells).
Conclusions:
- The developed HCI assay offers a robust, rapid, and cost-effective method for cell cycle distribution analysis.
- This phenotypic assay is valuable for small molecule mechanism of action studies and drug toxicity profiling.
- The assay's multiplexing potential enhances its utility in detailed cellular response investigations.


